Relay: The Recent Market Excitement Ignores The Reality Of Clinical Risks And Patent Cliffs

Summary

A Seeking Alpha opinion piece argues that recent market enthusiasm for Relay Therapeutics overlooks clinical risks and patent cliffs. The article text itself was not provided, so no specific data, drugs, or trial details could be extracted.